论文部分内容阅读
目的了解浙江省台州市农村地区妇女宫颈癌及癌前病变的发病现状,为该地区宫颈癌防治提供依据。方法于2012年6-12月对台州市海门、白云街道35～59岁妇女开展“三阶梯”宫颈癌筛查,即妇科、阴道分泌物、宫颈脱落细胞检查,脱落细胞检查结果可疑或异常者行阴道镜检查,阴道镜检查结果可疑或异常者再进一步宫颈多点活检后行组织病理学诊断。结果筛查6639人,筛查率65.58%,宫颈脱落细胞液基薄层细胞检测(TCT)阳性226例(3.40%)。147例(65.04%)TCT阳性妇女进行了宫颈组织细胞学检查,检出宫颈癌7例(4.76%),宫颈癌前病变56例(38.10%);宫颈癌前病变、宫颈癌在高度鳞状上皮内病变(HSIL)阳性妇女中检出率最高(63.33%,P<0.01);宫颈癌前病变、宫颈癌分别在35～49岁、50～59岁TCT阳性妇女中检出率较高,但差异无统计学意义(P>0.05)。结论台州市农村地区不同年龄阶段妇女宫颈癌及癌前病变患病率均较高,但筛查率低,尤其是低年龄组妇女(35～49岁),需进一步加强宫颈癌防治宣传教育,提高宫颈癌筛查率。
Objective To understand the incidence of cervical cancer and precancerous lesions in rural women in Taizhou, Zhejiang Province, and to provide evidence for the prevention and treatment of cervical cancer in this area. Methods From June to December 2012, women with 35- to 59-year-old women in Haimen and Baiyun streets of Taizhou City were screened for cervical cancer with gynecological and vaginal discharge, exfoliated cervical cells and suspicious or exfoliative cells Abnormal line colposcopy, colposcopy suspicious or abnormal results and then further multi-biopsy cervix histopathological diagnosis. RESULTS: 6639 people were screened, the screening rate was 65.58%, and 226 (3.40%) were positive for TCT of cervical exfoliated cells. Cervical cytology was performed in 147 cases (65.04%) of TCT positive women. Cervical cancer was detected in 7 cases (4.76%), cervical precancerous lesions in 56 cases (38.10%), cervical precancerous lesions, The positive rate of HSIL-positive women was the highest (63.33%, P <0.01). The incidences of cervical precancerous lesions and cervical cancer were 35-49 years old and 50- 59 years old, respectively. But the difference was not statistically significant (P> 0.05). Conclusion The prevalence rates of cervical cancer and precancerous lesions are higher in women of different ages in rural areas of Taizhou City, but the screening rate is low, especially for women in the lower age group (35-49 years old). It is necessary to further strengthen the publicity and education on cervical cancer prevention, Improve cervical cancer screening rate.